lysophosphatidic acid has been researched along with Arteriosclerosis, Coronary in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daida, H; Dohi, T; Kishimoto, T; Kojima, T; Kurano, M; Kurata, T; Miyauchi, K; Miyazaki, T; Nakamura, K; Nishino, A; Ogita, M; Ohkawa, R; Shimada, K; Tamura, H; Yaginuma, K; Yanagisawa, N; Yatomi, Y; Yokoyama, K | 1 |
| Brandon, JA; Morris, AJ; Mueller, P; Smyth, SS; Yang, F | 1 |
| Abdel-Latif, A; Heron, PM; Morris, AJ; Smyth, SS | 1 |
| Goudevenos, JA; Lourida, ES; Papathanasiou, AI; Tselepis, AD | 1 |
2 review(s) available for lysophosphatidic acid and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.
Topics: Adipose Tissue; Animals; Apolipoproteins E; Atherosclerosis; Coronary Artery Disease; Genetic Predisposition to Disease; Humans; Lysophospholipids; Mice; Mice, Knockout; Phosphatidate Phosphatase; Phosphoric Diester Hydrolases; Plaque, Atherosclerotic; Risk; Sphingosine | 2014 |
Lysophospholipids in coronary artery and chronic ischemic heart disease.
Topics: Animals; Atherosclerosis; Coronary Artery Disease; Humans; Lysophospholipids; Myocardial Ischemia; Signal Transduction; Sphingosine | 2015 |
2 other study(ies) available for lysophosphatidic acid and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Increased lysophosphatidic acid levels in culprit coronary arteries of patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Coronary Artery Disease; Coronary Circulation; Coronary Thrombosis; Cross-Sectional Studies; Female; Humans; Lipids; Lysophosphatidylcholines; Lysophospholipids; Male; Middle Aged; Platelet Activation; Prospective Studies | 2013 |
The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Antigens; Autoantibodies; Coronary Artery Disease; Female; Humans; Lipid Metabolism; Lipoproteins, LDL; Lysophospholipids; Male; Middle Aged; Oxidation-Reduction | 2006 |